3068/217908 A Phase III Randomized Trial of Heated Intraperitoneal Chemotherapy (HIPEC) with Cisplatin versus no HIPEC at the Time of Optimal Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Sponsor:

GOG Foundation

Sponsor Study ID:

GOG-3068

CTO #:

103913

NCT Number:

NCT05659381

Phase:

III

Protocol Type:

Treatment

Age Group:

Adults

Disease Sites:

Other Female Genital; Ovary

Study Objectives:

To determine if a single treatment with intraoperative HIPEC with cisplatin at the time of iCRS will result in improved PFS as compared to iCRS alone in patients with stage III or IV EOC who are treated with neoadjuvant IV platinum-based chemotherapy followed by niraparib maintenance.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)